David Benedicto

BAE Systems, Inc. provides support and service solutions for defense, intelligence and civilian systems. The firm offers ship repair, maintenance, modernization, conversion and overhaul services for the U.S. Navy, government, commercial and private customers. It operates full-service shipyards in Alabama, Florida, California, Virginia and Hawaii. The company was founded on November 30, 1999 and is headquartered in Arlington, VA.

Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA.